donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
ABMT ADVANCED BIOMEDICAL TECHNOLOGIES
0.0690.0000.00%
YOY
Do not show
Hide blank lines
(Q3)2021/07/31(Q2)2021/04/30(Q1)2021/01/31(FY)2020/10/31
Total revenue
-81.27% 180 145.02% 95 -21.93% 47.23K 960.2% 123.59K
Operating revenue
-81.27% 180 145.02% 95 -21.93% 47.23K 960.2% 123.59K
Cost of revenue
-95.37% 38 127.59% 32 -69.37% 10.15K 582.16% 51.82K
Gross profit
0.71% 142 166.32% 63 35.48% 37.09K 1667.3% 71.77K
Operating expense
-4.27% 111.91K -5.91% 113.21K 9097.37% 125.73K -35.51% 392.59K
Selling and administrative expenses
-14.31% 50.7K -31.26% 44.16K -20.44% 43.19K -15.1% 275.07K
-General and administrative expense
-14.31% 50.7K -31.26% 44.16K -20.44% 43.19K -15.1% 275.07K
Research and development costs
27.73% 54.63K 37.14% 56.65K 17.66% 66.81K -30.6% 182.96K
Depreciation amortization depletion
-55.05% 6.58K -15.55% 12.41K -1.37% 15.74K 185.42% 60.37K
-Depreciation and amortization
-55.05% 6.58K -15.55% 12.41K -1.37% 15.74K 185.42% 60.37K
Other operating expenses
-- -- -- -- -- -- -- -125.81K
Operating profit
4.28% -111.77K 6.04% -113.15K -440.84% -88.64K 46.95% -320.82K
Net non-operating interest income expense
2.58% -81.75K 5.24% -80.15K 9.28% -77.05K -0.77% -328.9K
Non-operating interest income
-37.5% 5 200% 15 1380% 74 83.33% 44
Non-operating interest expense
-2.58% 81.76K -5.23% 80.16K -9.2% 77.13K 0.78% 328.94K
Other net income (expense)
-14.37% -5.19K 190.41% 4.21K -30.59% -6.35K -25.92% -22.28K
Other non- operating income (expenses)
-14.37% -5.19K 190.41% 4.21K -30.59% -6.35K -25.92% -22.28K
Income before tax
3.17% -198.71K 9.81% -189.09K -169.71% -172.04K 29.18% -672K
Income tax
0 0 0 0
Net income
3.17% -198.71K 9.81% -189.09K -169.71% -172.04K 29.18% -672K
Net income continuous Operations
3.17% -198.71K 9.81% -189.09K -169.71% -172.04K 29.18% -672K
Minority interest income
0 0 0 0
Net income attributable to the parent company
3.17% -198.71K 9.81% -189.09K -169.71% -172.04K 29.18% -672K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
3.17% -198.71K 9.81% -189.09K -169.71% -172.04K 29.18% -672K
Basic earnings per share
3.65% -0.0028 10.17% -0.0027 -168.35% -0.0025 0% -0.01
Diluted earnings per share
3.65% -0.0028 10.17% -0.0027 -168.35% -0.0025 0% -0.01
Dividend per share
Currency Unit
USDUSDUSDUSD
Audit Opinions
------Unqualified Opinion with Explanation

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...